Drugs / rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002428 | — | HIV infectious disease | United Biomedical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rgp120/HIV-1MN Monovalent Octameric V3 Peptide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002428 ↗ |
| Modality | Vaccine | “monovalent HIV-1 MN synthetic branched peptide candidate vaccine” NCT00002428 ↗ |
| Route | Intramuscular | “intramuscular administration” NCT00002428 ↗ |